由柳葉刀出版。國際標準書號：1470-2045。《柳葉刀腫瘤學》是一本月刊，評論期刊，在腫瘤學上發表文章、觀點、新聞和評論。歷史《柳葉刀腫瘤學》于2000年9月出版，是一本生動、內容豐富的月刊，涵蓋了與全球臨床癌癥專家相關的國際問題。2005年5月，《華爾街日報》擴大了原有的研究范圍，并在印刷出版之前首先在網上發表文章。該雜志很快成為世界上最重要的原始研究出版物之一，特別是臨床試驗報告，以及在倡導和全球衛生領域。唯一的是，所有的原始研究都是通過一個快速的服務進行同行評審的，成功的論文在提交后的8周內發表。2008年，《華爾街日報》將其在線業務擴展到定期播客。柳葉刀腫瘤學也因主辦腫瘤學家、癌癥研究者和決策者的活動而享有盛譽。2007年，柳葉刀腫瘤學在新加坡召開了第一次會議，題為“21世紀的亞洲和癌癥管理”。另外，在2007，該雜志在舊金山、CA、美國的腫瘤學大會上主持了一個關于發展生物學、自我更新和癌癥的專題講座。隨后幾年，該雜志在2008年腫瘤大會和2009年亞洲腫瘤峰會上主持了第二次全體會議。2010年，柳葉刀腫瘤學“參與”會議的活動進一步擴大，包括在印度尼西亞巴厘島舉行的第二次亞洲腫瘤學峰會，以及在荷蘭阿姆斯特丹舉行的關于人乳頭狀瘤病毒和癌癥的會議。自2011年以來，《柳葉刀》繼續主辦成功的亞洲腫瘤峰會，2015年，《柳葉刀》將在中國上海舉辦2015年4月10日至12日舉行的第七屆亞洲腫瘤峰會。計劃在2016年及以后舉辦更多活動。該雜志還通過與特定組織和社會合作，參與癌癥健康保健的宣傳。聲譽和影響柳葉刀腫瘤學的影響因子為24.725。該期刊在全球202種腫瘤期刊中排名第三，是領先的臨床腫瘤研究期刊，在全球任何學科的所有科學期刊中排名前0.5%（2013年期刊引文報告，湯森路透2014年）。發表在《柳葉刀腫瘤學》上的文章定期在主流印刷媒體、在線媒體和廣播媒體上得到報道。新聞報道柳葉刀腫瘤學的目的是發表有趣的，信息豐富的，實踐變化的文章，任何與臨床腫瘤學相關的主題。主題包括但不限于：乳腺癌內分泌系統癌胃腸道癌泌尿生殖癌婦科癌癥血液學癌癥頭頸癌神經腫瘤學兒科腫瘤學胸腫瘤肉瘤皮膚癌流行病學、癌癥預防和癌癥控制支持性護理成像衛生保健系統

PUBLISHED BY THE LANCET. ISSN: 1470-2045.THE LANCET ONCOLOGY IS A MONTHLY, REVIEW JOURNAL, WITH ARTICLES, VIEWPOINTS, NEWS AND REVIEWS IN ONCOLOGY.HISTORYTHE LANCET ONCOLOGY WAS LAUNCHED IN SEPTEMBER, 2000, AS A LIVELY AND INFORMATIVE MONTHLY JOURNAL COVERING INTERNATIONAL ISSUES RELEVANT TO CLINICAL CANCER SPECIALISTS WORLDWIDE. IN MAY, 2005, THE JOURNAL EXPANDED TO INCLUDE ORIGINAL RESEARCH AND BEGAN PUBLISHING ARTICLES ONLINE FIRST PRIOR TO PRINT PUBLICATION. THE JOURNAL QUICKLY ESTABLISHED ITSELF AS ONE OF THE PREMIER PUBLICATIONS WORLDWIDE FOR ORIGINAL RESEARCH, ESPECIALLY REPORTS FROM CLINICAL TRIALS, AND IN THE AREAS OF ADVOCACY AND GLOBAL HEALTH. UNIQUELY, ALL ORIGINAL RESEARCH IS PEER-REVIEWED VIA A FAST-TRACK SERVICE, AND SUCCESSFUL PAPERS ARE PUBLISHED WITHIN 8 WEEKS OF SUBMISSION. IN 2008, THE JOURNAL EXPANDED ITS ONLINE PRESENCE TO INCLUDE REGULAR PODCASTS.THE LANCET ONCOLOGY HAS ALSO DEVELOPED A REPUTATION FOR HOSTING EVENTS FOR ONCOLOGISTS, CANCER RESEARCHERS, AND POLICYMAKERS. IN 2007, THE LANCET ONCOLOGY CONVENED ITS FIRST CONFERENCE IN SINGAPORE ENTITLED ASIA AND CANCER MANAGEMENTIN THE 21ST CENTURY. ADDITIONALLY IN 2007, THE JOURNAL HOSTED A PLENARY LECTURE AT THE ONCOLOGY CONGRESS IN SAN FRANCISCO, CA, USA, ON THE TOPIC OF DEVELOPMENTAL BIOLOGY, SELF RENEWAL, AND CANCER. IN SUBSEQUENT YEARS, THE JOURNAL HOSTED A SECOND PLENARY LECTURE AT THE 2008 ONCOLOGY CONGRESS, AND THE INAUGURAL ASIAN ONCOLOGY SUMMIT IN 2009. IN 2010, THE LANCET ONCOLOGY''''''''S INVOLVEMENT IN CONFERENCES EXPANDED WITH FURTHER EVENTS, INCLUDING A SECOND ASIAN ONCOLOGY SUMMIT IN BALI, INDONESIA, AND A CONFERENCE ON HPV AND CANCER IN AMSTERDAM, THE NETHERLANDS. SINCE 2011, THE JOURNAL HAS CONTINUED TO HOST THE SUCCESSFUL ASIAN ONCOLOGY SUMMITS AND IN 2015, THE LANCET ONCOLOGY WILL HOST THE 7TH ASIAN ONCOLOGY SUMMIT TO TAKE PLACE APRIL 10-12, 2015 IN SHANGHAI, CHINA. FURTHER EVENTS ARE PLANNED FOR 2016 AND BEYOND. THE JOURNAL IS ALSO INVOLVED IN CANCER HEALTH-CARE ADVOCACY BY PARTNERING WITH SPECIFIC ORGANISATIONS AND SOCIETIES.REPUTATION AND IMPACTTHE LANCET ONCOLOGY HAS AN IMPACT FACTOR OF 24·725. THE JOURNAL RANKS THIRD OUT OF 202 ONCOLOGY JOURNALS WORLDWIDE, IS THE LEADING CLINICAL ONCOLOGY RESEARCH JOURNAL, AND IS IN THE TOP 0·5% OF ALL SCIENTIFIC JOURNALS, OF ANY DISCIPLINE, GLOBALLY (2013 JOURNAL CITATION REPORTS?, THOMSON REUTERS 2014). ARTICLES PUBLISHED IN THE LANCET ONCOLOGY REGULARLY RECEIVE COVERAGE IN THE MAINSTREAM PRINT, ONLINE, AND BROADCAST MEDIA.COVERAGETHE AIM OF THE LANCET ONCOLOGY IS TO PUBLISH INTERESTING, INFORMATIVE, AND PRACTICE-CHANGING ARTICLES ON ANY TOPIC CONNECTED WITH CLINICAL ONCOLOGY. TOPICS INCLUDE, BUT ARE NOT LIMITED TO: BREAST CANCER ENDOCRINE SYSTEM CANCER GASTROINTESTINAL CANCER GENITOURINARY CANCER GYNAECOLOGICAL CANCER HAEMATOLOGICAL CANCER HEAD AND NECK CANCER NEUROONCOLOGY PAEDIATRIC ONCOLOGY THORACIC ONCOLOGY SARCOMA SKIN CANCER EPIDEMIOLOGY, CANCER PREVENTION, AND CANCER CONTROL SUPPORTIVE CARE IMAGING HEALTH-CARE SYSTEMS